SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-023257
Filing Date
2023-05-19
Accepted
2023-05-19 16:17:01
Documents
15
Period of Report
2023-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-20230517.htm   iXBRL 8-K 126296
2 EX-3.1 life-ex3_1.htm EX-3.1 17499
3 EX-10.1 life-ex10_1.htm EX-10.1 159019
4 EX-14.1 life-ex14_1.htm EX-14.1 97920
  Complete submission text file 0000950170-23-023257.txt   573374

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230517_lab.xml EX-101.LAB 13897
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230517_pre.xml EX-101.PRE 11429
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230517.xsd EX-101.SCH 2470
9 EXTRACTED XBRL INSTANCE DOCUMENT life-20230517_htm.xml XML 4891
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 23940293
SIC: 2836 Biological Products, (No Diagnostic Substances)